CompuMed, Inc. (CMPD)
OTCMKTS · Delayed Price · Currency is USD
3.880
+0.080 (2.11%)
Sep 26, 2025, 11:26 AM EDT
CompuMed Market Cap
CompuMed has a market cap or net worth of $5.04 million as of September 26, 2025. Its market cap has increased by 72.34% in one year.
Market Cap
5.04M
Enterprise Value
n/a
Revenue
1.69M
Ranking
n/a
PE Ratio
n/a
Stock Price
$3.88
Market Cap Chart
Since August 21, 1990, CompuMed's market cap has increased from 230.32K to 5.04M, an increase of 2,087.28%. That is a compound annual growth rate of 9.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2025 | 5.04M | 0.04% |
| Dec 31, 2024 | 5.04M | 92.57% |
| Dec 28, 2023 | 2.62M | -49.93% |
| Dec 30, 2022 | 5.22M | -57.41% |
| Dec 30, 2021 | 12.26M | 48.66% |
| Dec 31, 2020 | 8.25M | -26.25% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 789.71M |
| Tian'an Technology Group | 705.53M |
| Elite Pharmaceuticals | 686.78M |
| Glass House Brands | 541.39M |
| Northwest Biotherapeutics | 375.87M |
| CytoDyn | 358.21M |
| American Oncology Network | 335.84M |
| Nika Pharmaceuticals | 299.34M |